Search research articles
Contact Us
Filters
Showing results (51-60 of 70) with videos related to
Page
of 7
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
August 7, 2024
Retinal layer thinning for monitoring disease-modifying treatment in relapsing multiple sclerosis-Evidence for applying a rebaselining concept
Gabriel Bsteh, Harald Hegen, Nik Krajnc, et al.
Neurology and Therapy
|
May 16, 2020
Quality of Life Improves with Alemtuzumab Over 6 Years in Relapsing-Remitting Multiple Sclerosis Patients with or without Autoimmune Thyroid Adverse Events: Post Hoc Analysis of the CARE-MS Studies
Antonio Bertolotto, Rafael Arroyo, Elisabeth G Celius, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
August 6, 2010
The management of multiple sclerosis in children: a European view
Angelo Ghezzi, Brenda Banwell, Alexey Boyko, et al.
Journal of Neurology
|
February 10, 2018
MRI of the first event in pediatric acquired demyelinating syndromes with antibodies to myelin oligodendrocyte glycoprotein
Matthias Baumann, Astrid Grams, Tanja Djurdjevic, et al.
Journal of Neurology
|
June 9, 2026
Integration of retinal layer thinning into NEDA-3 predicts disability progression in multiple sclerosis
Fabian Föttinger, Nik Krajnc, Klaus Berek, et al.
Annals of Neurology
|
January 24, 2022
B Cell Depletion and SARS-CoV-2 Vaccine Responses in Neuroimmunologic Patients
Barbara Kornek, Fritz Leutmezer, Paulus S Rommer, et al.
Annals of Clinical and Translational Neurology
|
August 5, 2025
The rs10191329 Risk Allele Is Associated With Pronounced Retinal Layer Atrophy in Multiple Sclerosis
Gabriel Bsteh, Ruchi Tanavade, Nik Krajnc, et al.
Annals of the Rheumatic Diseases
|
August 17, 2022
Immunogenicity and safety of a fourth COVID-19 vaccination in rituximab-treated patients: an open-label extension study
Daniel Mrak, Elisabeth Simader, Daniela Sieghart, et al.
Annals of the Rheumatic Diseases
|
January 14, 2022
Additional heterologous versus homologous booster vaccination in immunosuppressed patients without SARS-CoV-2 antibody seroconversion after primary mRNA vaccination: a randomised controlled trial
Michael Bonelli, Daniel Mrak, Selma Tobudic, et al.
Journal of Neurology
|
October 19, 2023
Multiple sclerosis in the elderly: a retrospective cohort study
Anne Zinganell, Georg Göbel, Klaus Berek, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 70) with videos related to
Sort By:
Page
of 7
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
August 7, 2024
Retinal layer thinning for monitoring disease-modifying treatment in relapsing multiple sclerosis-Evidence for applying a rebaselining concept
Gabriel Bsteh, Harald Hegen, Nik Krajnc, et al.
Neurology and Therapy
|
May 16, 2020
Quality of Life Improves with Alemtuzumab Over 6 Years in Relapsing-Remitting Multiple Sclerosis Patients with or without Autoimmune Thyroid Adverse Events: Post Hoc Analysis of the CARE-MS Studies
Antonio Bertolotto, Rafael Arroyo, Elisabeth G Celius, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
August 6, 2010
The management of multiple sclerosis in children: a European view
Angelo Ghezzi, Brenda Banwell, Alexey Boyko, et al.
Journal of Neurology
|
February 10, 2018
MRI of the first event in pediatric acquired demyelinating syndromes with antibodies to myelin oligodendrocyte glycoprotein
Matthias Baumann, Astrid Grams, Tanja Djurdjevic, et al.
Journal of Neurology
|
June 9, 2026
Integration of retinal layer thinning into NEDA-3 predicts disability progression in multiple sclerosis
Fabian Föttinger, Nik Krajnc, Klaus Berek, et al.
Annals of Neurology
|
January 24, 2022
B Cell Depletion and SARS-CoV-2 Vaccine Responses in Neuroimmunologic Patients
Barbara Kornek, Fritz Leutmezer, Paulus S Rommer, et al.
Annals of Clinical and Translational Neurology
|
August 5, 2025
The rs10191329 Risk Allele Is Associated With Pronounced Retinal Layer Atrophy in Multiple Sclerosis
Gabriel Bsteh, Ruchi Tanavade, Nik Krajnc, et al.
Annals of the Rheumatic Diseases
|
August 17, 2022
Immunogenicity and safety of a fourth COVID-19 vaccination in rituximab-treated patients: an open-label extension study
Daniel Mrak, Elisabeth Simader, Daniela Sieghart, et al.
Annals of the Rheumatic Diseases
|
January 14, 2022
Additional heterologous versus homologous booster vaccination in immunosuppressed patients without SARS-CoV-2 antibody seroconversion after primary mRNA vaccination: a randomised controlled trial
Michael Bonelli, Daniel Mrak, Selma Tobudic, et al.
Journal of Neurology
|
October 19, 2023
Multiple sclerosis in the elderly: a retrospective cohort study
Anne Zinganell, Georg Göbel, Klaus Berek, et al.
Page
of 7